Correlation Between DiaMedica Therapeutics and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Checkpoint Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Checkpoint Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and Checkpoint Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between DiaMedica and Checkpoint is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Checkpoint Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.12 times less return on investment than Checkpoint Therapeutics. In addition to that, DiaMedica Therapeutics is 1.01 times more volatile than Checkpoint Therapeutics. It trades about 0.21 of its total potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.24 per unit of volatility. If you would invest 349.00 in Checkpoint Therapeutics on September 4, 2024 and sell it today you would earn a total of 82.00 from holding Checkpoint Therapeutics or generate 23.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Checkpoint Therapeutics
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Checkpoint Therapeutics |
DiaMedica Therapeutics and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Checkpoint Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Checkpoint Therapeutics vs. Candel Therapeutics | Checkpoint Therapeutics vs. Cingulate Warrants | Checkpoint Therapeutics vs. Unicycive Therapeutics | Checkpoint Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| CEOs Directory Screen CEOs from public companies around the world |